Top Chicago, IL Biotech Companies (39)
Don't see your company?
Create a company profile_0.jpg)
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer genetic evaluations at point of care, and design a tailored cancer prevention plan - we can help healthcare systems get ahead of this costly and emotionally devastating disease.
It’s not a debate. There’s no two sides. A post-pollution world is inevitable. Humans will either be part of it, or the planet will go on without us. In other words, it’s defossilize or die. But where others see a dire choice, LanzaTech sees a trillion-dollar opportunity. The good news is after 15 years, north of a thousand patents, and millions of hours of pioneering scientific inquiry, LanzaTech has invented a technology big enough to meet the moment. One that transforms pollution into profit, and ensures that humans continue to prosper far into the post-pollution future. The science is state-of-the-art, but the idea is simple. We use nature to heal nature. First we capture carbon emissions. Then we feed them into bioreactors where trillions of carbon-hungry microbes go to work. These tiny dynamos eat the pollution and output valuable raw material commodities. Pure enough to be resold, repurposed, recycled, renewed, re-everythinged — from sustainable jet fuel to yoga pants. It’s a commercial scale solution that’s ready for market today. In a crowded sector filled with speculation but short on results, our plug-and-play platform is already making our customers money. Turns out science and business makes one helluva team. Waste carbon pollution is humanity’s biggest threat. LanzaTech is turning it into an opportunity. Reducing emissions and making money for our customers — today. Let's transform our tired Lose-Lose climate debate into a Win-Win proposition. One that helps companies grow their revenue while helping the planet reach a post-pollution reality.
Gerresheimer is the global partner for pharma, biotech, healthcare and cosmetics with a very broad product range for pharmaceutical and cosmetic packaging and drug delivery devices. The company is an innovative solution provider from concept to delivery of the end product. Gerresheimer achieves its ambitious goals through a high level of innovative strength, industrial competence, focus on quality and customers. In developing innovative and sustainable solutions, Gerresheimer relies on a comprehensive international network with numerous innovation and production centers in Europe, America and Asia. Gerresheimer produces close to its customers worldwide with around 10,000 employees and generates annual sales of more than €1.5 billion. With its products and solutions, Gerresheimer plays an essential role in people's health and well-being.
Portal Innovations is a venture development engine focused on early stage life science enterprises. Our crafted capital approach provides management expertise, funding, and lab+work space to turn breakthroughs into businesses. Our market-based approach identifies the most promising life science startups, and supports them throughout the journey. We engage deeply in every aspect of the business, leveraging our network to tackle each company’s specific challenges and lead them to successful Series A investments with world-class VCs and strategic investors.
Talis is developing a new class of diagnostic platform to enable rapid, high-complexity testing across a wide range of healthcare settings. Testing for COVID-19 is in high demand. Learn more about our product options. GenBody COVID-19 Ag Test Minimize disruptions with high-volume SARS-CoV-2 antigen testing and results in 15 minutes Learn more: https://talisbio.com/genbody-covid-19-antigen-test/ TALIS ONE™ COVID-19 TEST SYSTEM Rapid point-of-care COVID-19 test that enables highly sensitive SARS-CoV-2 RNA detection from nasal mid-turbinate swabs in less than 30 minutes. With its dual-gene target design, test sensitivity and inclusivity of variants are optimized. Learn more: https://talisbio.com/talis-one-covid-19-test-system/ Our visionary team combines depth of experience with passion to deliver a pioneering solution to infectious disease diagnostics. Infectious disease treatment today is largely guideline-driven: treat patients with similar symptoms the same. Unfortunately, similar symptoms can often have very different causes. Our tests will enable caregivers to know within minutes, the cause of illness, as well as which medications will be effective for their patient, empowering them to provide individualized care rather than broad, guideline-dictated treatments. From the doctor’s office to the hospital bedside to remote care settings, we are re-defining the treatment of infectious diseases.
Livongo Health is taking a bold step to change how we manage chronic conditions, starting with diabetes. Livongo Health is taking a bold step to change how we manage chronic conditions, starting with diabetes. We're helping people better understand their bodies by providing an interactive program that translates data into real-time, actionable
rMark Bio applies propriatary analytics to help pharmaceutical companies identify academic researchers to partner with during new drug research and development. Our solution reduces the man hours wasted manually gathering and understanding info about academic scientists, while simultaneously providing higher value partnership opportunities.
_0.jpg)
At Livongo, we empower people with chronic conditions to live a better life! We’re helping people better understand their bodies by providing an interactive program that translates data into real-time, actionable information, leading to smart and informed health decisions.
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm.
Cardiosense is building a physiological monitoring platform to help manage cardiac diseases such as heart failure and hypertension.
Work Your Passion. Live Your Purpose.
